Pharma Surge

Pharma Surge

🇬🇧·3d agoResearch

rAAV production cost analysis: Indication-specific cost per dose and reduction strategies

Publisher

N
Nature Gene Therapy

UK

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Nature Gene Therapy
Region
UK
Scope
Research
Published
July 21, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on nature.com

Leave the platform to read the original full article on the publisher site.

Source: Nature Gene Therapy

Scope: Research

Open original article
rAAV production cost analysis: Indication-specific cost per dose and reduction strategies | Pharma Surge